Skip to main content
Premium Trial:

Request an Annual Quote

Beginning to Pay Off

China's investment in biotech is beginning to pay off, Reuters reports.

China's funding for biotech quadrupled to $191 billion in 2005 to 2013 while its Thousand Talents Program also lured Chinese researchers working abroad to return, and this, Reuters says, enabled "China to jump quickly on promising new technologies, often first developed elsewhere."

The CRISPR-Cas9 technology has been a particular focus — researchers from Sun-Yat Sen University published, to much controversy, their work using the tool to edit non-viable human embryos, and Reuters adds that other Chinese labs are also exploring use of the tool. About a fifth of gene-editing patent applications are from Chinese entities, it says.

Gene sequencing, such as at BGI, it adds, has been another focus.

"The Chinese could, over time, play a very significant role in this game as they have a very entrepreneurial attitude — much more so than in parts of Europe," Rodger Novak, CEO of CRISPR Therapeutics, tells Reuters.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.